Drawing for ANGIOTECH PHARMACEUTICALS

USPTO serial 77190964

ANGIOTECH PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JOHNSON, AISHA CLARKE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ANGIOTECH PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevin S. Costanza

KEVIN S. COSTANZA SEED IP LAW GROUP PLLC701 5TH AVE STE 5400SEATTLE, WA 98104-7064UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001hybrid hydrogel polymer coating layers applied to medical devices for use in the manufacture of such devices, into which drugs and bioactive agents can be incorporated for use with invasive and other medical proceduresACTIVE—
005medical adhesive for binding wounds and incisions; medical lubricant, namely, tissue lubricant for use with medical and surgical instruments for invasive or other medical procedures; liquid polymer with bioactive properties for treatment during surgery to control blood flow and for performing wound closure for use on surgical devices; bioactive pharmaceutical preparation for treatment during surgery, or for post operative conditions, for controlling blood flow and performing wound closure; anti-infective, antibiotics, anticancer drugs and other bioactive agents for the treatment of patients during surgery, or for post operative conditions, sold in the form of a controlled release polymer to be applied to medical devices used in invasive and other surgical procedures; bioactive preparations and anti-thrombogenics for the treatment of patients during surgery; drug-eluting bioresorbable preparations for delivering active reagents to selected bodily tissues; pharmaceutical preparations for wounds, namely, reagents having drug-eluting and bioresorbing characteristics that help prevent unwanted growth of bodily tissues; bone wax for use in preventing bone bleeding during surgical procedures; pharmaceutical preparations, namely, gels for application to medical bandages, dressings, and pads to speed hemostasis; gels for surgical application to bone and cartilage; synthetic and non-synthetic resorbable pharmaceutical liquids for surgical use for purposes of hemostasis and preventing adhesions; contrasting media for ultrasound diagnostic imaging; diagnostic reagents and contrast media for medical useACTIVE—
010hybrid hydrogel polymer coating layers applied to medical devices and sold as an integral component of such devices for surgical use, into which drugs and bioactive agents can be incorporated for use with invasive and other medical proceduresACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 2, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 2, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 31, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 6, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 2008NPUBNOTICE OF PUBLICATION—
Dec 2, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 1, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 20, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 20, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 11, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 31, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 31, 2008ALIEASSIGNED TO LIE—
Mar 20, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 25, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 25, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 27, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2007DOCKASSIGNED TO EXAMINER—
Jun 1, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance